Topic: Financial Times Ltd.
GlaxoSmithKline is going to cut R D and other expenses as part of an effort to lower costs. The company wouldn't specify how many jobs will be lost. But CEO Andrew Witty said that the figure in the U.K., where Glaxo is ...
Pharmaceutical company GlaxoSmithKline PLC on Monday declined to comment on published reports that it plans to cut thousands of jobs. Glaxo, which has about 99,000 employees in more than 100 countries, will announce its fourth-quarter results Thursday.
Pharmaceutical company GlaxoSmithKline PLC on Monday declined to comment on published reports that it plans to cut thousands of jobs.The Sunday Times, which did not identify a source for its report, said that GSK planned to announce up to 4,000 job cuts ...
The cuts keep coming from U.K. pharma. Just a few days after AstraZeneca said it would eliminate thousands of jobs, the London papers reported this weekend that GlaxoSmithKline is about to announce some big cuts of its own.. The Times of London ...
finance-related stories involving U.S., European and Asian . to buy a 51 percent stake in India's unlisted Shantha Biotech . after prospective bidder Sanofi Aventis dropped out, . * Abu Dhabi's Advance Technology Investment Co (ATIC) has . bid for Temasek's majority ...
In the never-ending guessing game called What Drug Company Is Going to Get Bought Next? Biogen CEO Jim Mullen, a man who is not unwilling to use a double negative, had this to say to the Financial Times: "We're in good shape, ...
Eli Lilly is resisting getting caught up in the wave of drug-industry consolidation.. After Pfizer-Wyeth, Merck/Schering-Plough and Roche-Genentech, Lilly CEO John Lechleiter told the Financial Times his company isn't interested in a mega-merger, and he ruled out a tie-up with Bristol-Myers Squibb.. ...
Looks like there may be more movement soon on the drug-industry M A front.. Potential takers of the company, which makes anti-itch creams, acne treatments and other dermatological remedies, include Johnson Johnson, Novartis and GlaxoSmithKline.. Separately, the Financial Times reports that Glaxo ...
With Pfizer buying Wyeth, Eli Lilly digesting ImClone and Roche maneuvering to seal the deal with Genentech, maybe Sanofi-Aventis figures it can make a big acquisition without getting sucked into a bidding war.. The company's new CEO Chris Viehbacher told employees Friday ...
The following corporate finance-related stories were reported by media on Monday: * Pfizer (nyse: PFE - news - people ) is willing to acquire a large rival drugs company to improve its financial health, Chief Executive Jeff Kindler was quoted by the ...
Photo Gallery
-
Skyscrapers For Sale
In this photo taken Tuesday, May 12, 2009, 1330 Avenue of the ...AP News - -
President Lee's interview with Financial Times
President Lee Myung-bak (R) speaks during an interview with the Financial Times ...ZUMA Press Inc - -
BRITAIN CLIMATE PROTEST
A man reads a copy of a spoof edition of Britain's ...AP News -
From Around the Web
Video Gallery
-
The Financial Times 15s Commercial
None2009-10-13 -
MIPIM 2011 - Keynote panel on economics ...
MIPIM brings together a leading European economist and a top-rank ...2011-03-09 -
Ron Paul 'Annoyed' at President Obama
Free email updates: www.RonPaul.comPlease like, share, subscribe & comment ...2011-07-24
